This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume. They also have a ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.